Requirement for increased IL-10 in the development of B-1 lymphoproliferative disease in a murine model of CLL. - Wikidata - awgldk - TriplyDB

Requirement for increased IL-10 in the development of B-1 lymphoproliferative disease in a murine model of CLL.

Requirement for increased IL-10 in the development of B-1 lymphoproliferative disease in a murine model of CLL.

http://www.wikidata.org/entity/Q37360750

about

Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas.Activation and differentiation of autoreactive B-1 cells by interleukin 10 induce autoimmune hemolytic anemia in Fas-deficient antierythrocyte immunoglobulin transgenic mice The New Zealand black mouse as a model for the development and progression of chronic lymphocytic leukemia.Assessing the potential carcinogenic activity of magnetic fields using animal models.Splenic marginal zone lymphomas of mice.Phosphatidylserine Outer Layer Translocation Is Implicated in IL-10 Secretion by Human Regulatory B Cells.Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function.The early protective thymus-independent antibody response to foot-and-mouth disease virus is mediated by splenic CD9+ B lymphocytes.A Hard(y) Look at B-1 Cell Development and Function.High Mda-7 expression promotes malignant cell survival and p38 MAP kinase activation in chronic lymphocytic leukemia

P2860

Q24649526-2217CCA5-9661-4A5A-827D-51744460FF0F Q24675006-9C5FCDCF-7815-494F-A799-2EC070787FF2 Q30837949-82DA2046-77D8-4C52-8B24-62061CB378A0 Q33343068-1A57946E-C781-42B1-AD0B-D75D51D4EBBA Q33691885-1ECD1B6F-711B-48F1-8C1C-57FDFE5467D0 Q33852795-4F8C2160-6636-4706-AACA-52612195BDDF Q35786204-45486E52-9C8B-468F-AAC2-D80172A298D7 Q36245606-ED974646-7A86-4096-8D82-91A908273A24 Q37091230-27DF1B91-BF6F-4757-9508-E46C3AF96313 Q42412876-492BECAC-260D-45C1-B5E0-71884188090A Q46130357-D9E1A00A-101E-4CBE-9D1E-3A80A4825030 Q58041746-E9F9FEEB-0585-436B-B324-E41AAF8952BF

P2860

Requirement for increased IL-10 in the development of B-1 lymphoproliferative disease in a murine model of CLL.

http://www.wikidata.org/entity/Q37360750

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 1996

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Requirement for increased IL-1 ...... ease in a murine model of CLL.

@en

Requirement for increased IL-1 ...... ease in a murine model of CLL.

@nl

type

label

Requirement for increased IL-1 ...... ease in a murine model of CLL.

@en

Requirement for increased IL-1 ...... ease in a murine model of CLL.

@nl

prefLabel

Requirement for increased IL-1 ...... ease in a murine model of CLL.

@en

Requirement for increased IL-1 ...... ease in a murine model of CLL.

@nl

P1433

Q37360750-C7125958-C4CD-4B10-BD5E-C527348306E2

P1476

Q37360750-380FE49C-3201-4D65-BF2C-77FD62C72364

P2093

Q37360750-08099BA3-EB50-4F94-A727-B3B344CDE9C7

Q37360750-309A440C-F9DE-456C-AB7F-2CF8B69D6633

Q37360750-802EF0FA-0328-491E-97A6-88CAB783C9D7

Q37360750-85F9E2DF-76C2-42D4-8C00-9EA777218F27

Q37360750-BB947F58-9C7B-4844-B844-ABC8DBE74A2A

P2860

Q37360750-07A87714-82C6-4E68-9A3A-EF502671C8C2

Q37360750-21345FB8-B657-4836-8D64-ACC79303CCDF

Q37360750-238FFF37-63F9-4B1D-8B15-9321A3563009

Q37360750-31DF04B5-9383-4142-B64A-70D3D6B98357

Q37360750-335C186A-1183-43DA-8117-213876DFD92E

Q37360750-44D6A987-55AC-4F7E-9C31-D7CE9C76A99C

Q37360750-4951E4F6-EECA-44CA-AFAA-F1AD6F12A936

Q37360750-4BB94A25-1184-4CBA-8F65-5B672315F348

Q37360750-501DC59A-C533-4C31-8ADB-C22F79F67D23

Q37360750-58A6F19D-DA7A-4D57-A084-1C3AA580607D

P304

Q37360750-21785AA7-9D08-432F-8525-E89D3E758CD1

P31

Q37360750-34B099F4-F881-4A65-A349-9A7629056BAE

P356

Q37360750-CD3DDB2C-8F3A-49F5-A450-9BE1A117F75B

P407

Q37360750-76BD3182-DE50-4168-BC6A-E493C891AEB7

P433

Q37360750-7130A5F4-4B3B-49B3-8661-ACEEF3899B59

P478

Q37360750-69DE0156-D5EB-41D2-9FBB-F2D2BAE7EF00

P577

Q37360750-8B1A8DE7-1AAB-4DFC-9843-CC04378C1BF3

P698

Q37360750-DDA6F197-AD58-45CC-8F07-EC199AD9B91E

P932

Q37360750-1DE84583-65DF-465A-803E-9DC49422EE43

P356

P1433

Journal of Clinical Investigation

P1476

Requirement for increased IL-1 ...... ease in a murine model of CLL.

@en

P2093

E Raveche

http://www.w3.org/2001/XMLSchema#string

G E Marti

http://www.w3.org/2001/XMLSchema#string

R A Metcalf

http://www.w3.org/2001/XMLSchema#string

S Ramachandra

http://www.w3.org/2001/XMLSchema#string

T Fredrickson

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes

Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes

Interleukin-10-deficient mice develop chronic enterocolitis

Ly-1 B-cell clones similar to human chronic lymphocytic leukemias routinely develop in older normal mice and young autoimmune (New Zealand Black-related) animals

Lupus susceptibility loci in New Zealand mice.

Genetic studies in NZB mice. I. Spontaneous autoantibody production.

Genetic studies in NZB mice. V. Recombinant inbred lines demonstrate that separate genes control autoimmune phenotype.

Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus.

BSAP: a key regulator of B-cell development and differentiation.

Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10.

P304

1788-1793

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI118978

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P577

1996-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8878429

http://www.w3.org/2001/XMLSchema#string

P932

507617

http://www.w3.org/2001/XMLSchema#string